Clinicians using Surescripts Real-Time Prescription Benefit noticed their patients were more likely to pick up their prescriptions, a key first step to medication adherence, according to a recent ...

– Validose, a 10XBeta Venture Studio portfolio company pioneering precision medication delivery, announced today the successful close of a $2 million pre-seed funding round. – The round was led by ...

ARLINGTON, Va.--(BUSINESS WIRE)--More than half of all prescribers in the United States (620,000) used Surescripts Real-Time Prescription Benefit in May 2022, an increase of 7.5% since December 2021.

Validose, a 10XBeta Venture Studio portfolio company pioneering precision medication delivery, announced recently the closing of a $2 million pre-seed funding round. The funding round was led by Peter ...

Ensuring medication adherence is a critical aspect of patient care, directly influencing treatment outcomes and overall health. However, accurately measuring adherence has been a persistent challenge ...